Group B Streptococcus (GBS) is a leading cause of perinatal infectious diseases, particularly neonatal sepsis and meningitis. GBS is a bacterium that normally resides in the genital and gastrointestinal tracts of healthy adults, but it can be transmitted to the newborn during childbirth. In pregnant women, GBS screening is routinely performed around the 35th to 37th week of gestation to identify carriers. Infants born to GBS-positive mothers are at an increased risk of developing early-onset GBS disease, manifesting within the first week of life. Clinical features of early-onset GBS disease include respiratory distress, fever, lethargy, and poor feeding. Late-onset GBS disease can occur between the second week and several months of life, presenting with symptoms such as meningitis, sepsis, and pneumonia. Prevention strategies involve intrapartum antibiotic prophylaxis for GBS-positive pregnant women, which has significantly reduced the incidence of early-onset disease.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France